TOR1AIP1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.479600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.501600E-01
Normal-vs-Stage2
8.701200E-01
Normal-vs-Stage3
5.191500E-02
Normal-vs-Stage4
3.136600E-01
Stage1-vs-Stage2
6.164400E-01
Stage1-vs-Stage3
4.476200E-02
Stage1-vs-Stage4
2.948800E-01
Stage2-vs-Stage3
1.041860E-03
Stage2-vs-Stage4
8.758100E-02
Stage3-vs-Stage4
4.588400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.789600E-01
Normal-vs-AfricanAmerican
4.938600E-01
Normal-vs-Asian
6.950000E-01
Caucasian-vs-AfricanAmerican
6.036200E-02
Caucasian-vs-Asian
6.499600E-01
AfricanAmerican-vs-Asian
1.720370E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.711400E-01
Normal-vs-Female
8.295600E-01
Male-vs-Female
8.802000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.464400E-01
Normal-vs-Age(41-60Yrs)
8.553000E-01
Normal-vs-Age(61-80Yrs)
7.670200E-01
Normal-vs-Age(81-100Yrs)
2.922800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.527200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.260000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.930000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.214400E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.784200E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.938000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.733600E-01
Normal-vs-Daily Drinker
1.403990E-01
Normal-vs-Weekly Drinker
8.984600E-01
Normal-vs-Occasional Drinker
9.155400E-01
Normal-vs-Social Drinker
9.634000E-01
Non Drinker-vs-Daily Drinker
1.947350E-01
Non Drinker-vs-Weekly Drinker
3.661800E-01
Non Drinker-vs-Occasional Drinker
7.049900E-02
Non Drinker-vs-Social Drinker
2.254400E-01
Daily Drinker-vs-Weekly Drinker
6.898300E-02
Daily Drinker-vs-Occasional Drinker
9.416100E-03
Daily Drinker-vs-Social Drinker
6.038000E-02
Weekly Drinker-vs-Occasional Drinker
6.841400E-01
Weekly Drinker-vs-Social Drinker
7.797600E-01
Occasional Drinker-vs-Social Drinker
9.404200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.498000E-02
Normal-vs-Grade 2
1.108400E-02
Normal-vs-Grade 3
2.137900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.629380E-01
Grade 1-vs-Grade 3
2.757000E-01
Grade 1-vs-Grade 4
7.498000E-02
Grade 2-vs-Grade 3
8.988000E-01
Grade 2-vs-Grade 4
1.108400E-02
Grade 3-vs-Grade 4
2.137900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.800000E-01
Normal-vs-NonDiabetic
7.126600E-01
Diabetic-vs-NonDiabetic
4.968600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.710800E-01
Normal-vs-NoPancreatitis
7.421400E-01
Pancreatitis-vs-NoPancreatitis
3.527400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.785400E-01
Normal-vs-N1
8.401200E-01
N0-vs-N1
9.167200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.158000E-01
Normal-vs-TP53-NonMutant
8.095600E-01
TP53-Mutant-vs-TP53-NonMutant
6.034400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
